Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1675 of 2228 entries
View as:

Safety and PK Study of BIBF 1120 in Japanese Patients With IPF

Phase: N/A Priority: Normal
NCT ID: NCT01136174 Org: User:
Start: 05/31/10 End: - Due: -

Renal Impairment Study of Empagliflozin (BI10773) in Japanese Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01581658 Org: User:
Start: 04/01/12 End: 11/01/12 Due: 11/01/13

Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 113823 Powder in Bottle (PiB) and Tablet in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02259972 Org: User:
Start: 01/31/10 End: - Due: -

A Randomised, Double- Blind, Placebo Controlled, Cross-over Efficacy and Safety Comparison of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for Four Weeks in Patients With Moderate Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01152450 Org: User:
Start: 07/31/10 End: - Due: -

A Double-blind, Randomised Study to Assess the Influence of Tiotropium (Spiriva®)

Phase: N/A Priority: Normal
NCT ID: NCT00257452 Org: User:
Start: 10/31/04 End: 07/31/05 Due: 07/31/06

A Study in Healthy Men to Test How the Body Takes up and Tolerates Different Doses of BI 474121, and Whether it Makes a Difference if BI 474121 is Taken as a Tablet or a Drink.

Phase: N/A Priority: Normal
NCT ID: NCT04194645 Org: User:
Start: 01/09/20 End: 03/25/21 Due: 03/25/22

Phase I Open Label Trial to Assess Safety of BIBW 2992 (Afatinib) in Combination With Herceptin® in Patients With HER2-positive Advanced Breast Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT00950742 Org: User:
Start: 08/01/09 End: 10/01/13 Due: 10/01/14

Tiotropium+Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 2)

Phase: N/A Priority: Normal
NCT ID: NCT02006732 Org: User:
Start: 11/30/13 End: 11/30/14 Due: 11/30/15

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses and Effect of Food on the Bioavailability of BI 1060469

Phase: N/A Priority: Normal
NCT ID: NCT01971502 Org: User:
Start: 10/31/13 End: 02/28/14 Due: 02/28/15

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 1026706 in Male and Female Healthy Subjects and Patients With Osteoarthritis of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT02126826 Org: User:
Start: 05/28/14 End: 10/21/14 Due: 10/21/15

Efficacy of a Standardised Bilberry Extract in Improving the Night Vision of Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02194361 Org: User:
Start: 12/31/99 End: - Due: -

A Study of the Safety and Efficacy of 4 Doses of BI 1744 CL Delivered Via the Respimat in Patients With Asthma.

Phase: N/A Priority: Normal
NCT ID: NCT01013753 Org: User:
Start: 02/28/10 End: 01/31/11 Due: 01/31/12

A Study in People With Colorectal Cancer to Test Whether Ezabenlimab or Pembrolizumab in Combination With BI 765063 Lead to Side Effects or Delays in Surgery

Phase: N/A Priority: Normal
NCT ID: NCT05446129 Org: User:
Start: 09/27/22 End: 11/08/23 Due: 11/08/24

Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02776683 Org: User:
Start: 06/08/16 End: 10/03/18 Due: 10/03/19

A Study in the United Sates That Looks at the Safety and Effectiveness of Pradaxa Pellets in Children Aged 3 Months to Less Than 12 Years Who Need Treatment of a Blood Clot or Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot

Phase: N/A Priority: Normal
NCT ID: NCT05966740 Org: User:
Start: 04/19/24 End: 04/28/25 Due: 04/28/26

A Study to Test Different Doses of BI 1569912 in People With Depression Who Take Anti-depressive Medicine

Phase: N/A Priority: Normal
NCT ID: NCT06280235 Org: User:
Start: 03/27/24 End: 03/11/25 Due: 03/11/26

Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroid (ICS)

Phase: N/A Priority: Normal
NCT ID: NCT01397201 Org: User:
Start: 07/01/11 End: 12/23/11 Due: 12/23/12

A Study in Healthy People to See How Zongertinib is Taken up Into the Blood When Given as Tablets Made by Two Different Manufacturers

Phase: N/A Priority: Normal
NCT ID: NCT06360081 Org: User:
Start: 04/30/24 End: 07/15/24 Due: 07/15/25

Using Telmisartan Alone or Combination of Telmisartan -HCTZ in the Treatment of Mild to Moderate Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00638911 Org: User:
Start: 09/30/04 End: - Due: -

Pharmacokinetics of Single and Multiple Oral Doses of BI 1356 in Healthy Chinese Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02183532 Org: User:
Start: 07/31/09 End: - Due: -

Bioavailability of BI 10773 and Sitagliptin in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02172196 Org: User:
Start: 05/31/09 End: - Due: -

Open Label Trial to Explore Safety of Combining Afatinib (BIBW 2992) and Radiotherapy With or Without Temozolomide in Newly Diagnosed Glioblastoma Multiform

Phase: N/A Priority: Normal
NCT ID: NCT00977431 Org: User:
Start: 09/17/09 End: 09/12/17 Due: 09/12/18

Efficacy and Tolerability of Sifrol® (Pramipexole) in Patients With Advanced Idiopathic Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02248220 Org: User:
Start: 10/31/98 End: - Due: -

Dose Escalation Study of BIBF 1120 in Patients With Advanced Gynaecological Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT02182245 Org: User:
Start: 10/01/05 End: - Due: -

Efficacy and Safety of B I1356 (Linagliptin) vs. Placebo Added to Metformin Background Therapy in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00601250 Org: User:
Start: 01/31/08 End: - Due: -